Path : Home > Industry > Boehringer Ingelheim acquires GST

Boehringer Ingelheim acquires GST


Sep 17, 2020
Boehringer Ingelheim joins forces with Belgian biotech company GST which develops and produces state-of-the art stem cell products for horses and pets.

The acquisition follows two years of successful partnership that brought the first-ever registered stem cell-based veterinary medicine to the European market.

Decision to acquire GST is fully aligned with part of Boehringer Ingelheim’s Animal Health strategy, aiming to strengthen its portfolio capabilities to accelerate innovation and growth.

The acquisition follows two years of successful partnership that brought the first-ever registered stem cell-based veterinary medicine to the European market.

Decision to acquire GST is fully aligned with part of Boehringer Ingelheim’s Animal Health strategy, aiming to strengthen its portfolio capabilities to accelerate innovation and growth.

 


  • Previous: Terri Boeser to oversee Trouw Nutrition USA¡¯s Companion Animal Division
  • Next: IK Investment Partners acquires Forthglade (UK)
  • Industry New

    Partner Links

    Go to Top

    HOME - About PetsGlobal.com - Useful Links - Advertise - Contact PetsGlobal.com

    Copyright 2001-2025 PetsGlobal.com All right reserved